Summary
The influence of moderate and low insulin antibody levels on insulin absorption and plasma free insulin profiles is uncertain. Two groups of six C-peptide negative diabetic patients, one with low (3.8±0.8 μ/l) and one with moderate (16.4±2.0 μg/l) serum insulin antibody levels, were studied. Subjects were given 0.3 U/kg neutral human or acid bovine soluble insulin subcutaneously in random order before breakfast on separate days. Moderate antibody levels significantly blunted the rise in plasma free insulin that followed injection of the human and bovine insulins (p<0.05). The rise in blood glucose after breakfast was significantly greater in patients with moderate antibody levels (p<0.05) and more marked following the bovine than the human insulin (p<0.05). Plasma free insulin, blood glucose and 3-hydroxybutyrate profiles suggest that acid bovine soluble insulin has a significantly more protracted action than neutral human insulin.
Article PDF
Similar content being viewed by others
References
Anderson OO, Egeberg J (1977) The clinical significance of insulin antibodies. Acta Paed Scand 270: 63–68
Reeves WG, Allen BR, Tattersall RB (1980) Insulin-induced lipoatrophy: evidence for an immune pathogenesis. Br Med J 280: 1500–1503
Madsbad S, Alberti KGMM, Binder C, Burrin JM, Faber OK, Krakup T, Regeur L (1979) Role of residual insulin secretion in protecting against ketoacidosis in insulin — dependent diabetics. Br Med 12: 1257–1259
Vaughan NJA, Matthews JA, Kurtz AB, Nabarro JDN (1983) The bioavailability of circulating antibody-bound insulin following insulin withdrawal in Type 1 (insulin-dependent) diabetes. Diabetologia 24: 355–358
Gray RS, Cowan P, Di Mario U, Clarke BF, Duncan LJP (1983) The influence of insulin binding antibodies on bovine and biosynthetic human insulin action in Type 1 diabetes. Diabetologia 25: 158 (Abstract)
Lloyd B, Burrin JM, Smyth P, Alberti KGMM (1978) Enzymatic fluorimetric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol and 3-hydroxybutyrate. Clin Chem 24: 1724–1729
Nakagawa S, Nakayamah H, Sassaki T, Yoshino K, Yune YY, Shinozaki K, Aoki S, Mashimo K (1973) A simple method for the determination of free insulin levels in insulin treated patients. Diabetes 22: 590–600
Soeldner J, Slone D (1965) Critical variables in the radioimmunoassay of serum insulin using the double antibody technique. Diabetes 14: 771–779
Reeves WG, Kelly U (1980) An immunochemical method for the quantitation of insulin antibodies. J Immunological Meth 34: 329–338
Home PD, Owens DR, Blain PG, Alberti KGMM (1982) A new look at the pharmacokinetics of subcutaneous injected human and porcine insulin. Diabetes 31: 58A
Koivisto VA, Felig P (1980) Alterations in insulin absorption and in blood glucose associated with varying insulin injection sites in diabetic patients. Ann Internal Med 92: 59–61
Berger M, Cüppers HJ, Hegner H, Jörgens V, Berchtold P (1982) Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 5: 77–91
Kinmouth AL, Baum JD (1980) Timing of pre-breakfast insulin injection and post-prandial metabolic control in diabetic children. Br Med J 280: 604–606
Francis AJ, Home PD, Hanning I, Alberti KGMM, Tunbridge WMG (1983) Intermediate acting insulin at bedtime: effect on blood glucose concentrations before and after breakfast. Br Med J 286: 1173–1176
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Francis, A.J., Hanning, I. & Alberti, K.G.M.M. The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins. Diabetologia 28, 330–334 (1985). https://doi.org/10.1007/BF00283138
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00283138